国家药品监督管理局根据1996年结束的全国中成药地方标准整顿工作后的现状,就遗留品种问题,为进一步强化中成药国家标准管理工作,维护药品监督管理法规的严肃性,为提高药品质量标准,形成以国家标准为主体的标准体系,分别于2000年12月13日～15日、12月18～20日分别在北京召开了解决中成药地方标准医学组专题研讨会和注册管理组专题研讨会。参加会议的代表为第七届药典委员会医学专业委员 The State Drug Administration supervised the status quo of the national standard for local Chinese patent medicines after the end of 1996. After the rectification of local standards for Chinese patent medicines that ended in 1996, the issue of legacy varieties was further strengthened in order to further strengthen the management of the national standards of Chinese patent medicines, maintain the solemnity of drug regulatory regulations, and improve the quality standards of pharmaceuticals. , Formed a national standard-based standard system, held in Beijing on December 13th to 15th and December 18th to 20th, respectively, in Beijing to discuss special topics of the seminars and registration groups of the local standard medicine group of Chinese patent medicines. meeting. Representatives attending the meeting are medical professional members of the 7th Pharmacopoeia Commission